Insiders picked up the pace of buying last week as the number of companies reporting purchases moved north of 200 for the first time in at least a month. Hopefully, the uptick means boardroom confidence for the economy's prospects are on the upswing for the back half of 2014 ��fingers crossed for the millions that have given up on finding a job.
While, unfortunately, many good people are losing hope for finding rewarding work, at least one insider at Whole Foods Market, Inc. (NASDAQ:WFM) hasn't given up on the "organic" grocer despite hitting an earnings-driven rough patch.
Whole Foods is a retailer of natural and organic foods. The Company operates in one segment: natural and organic foods supermarkets. As of May 6, 2014, the company operated 374 stores in the United States, Canada, and the United Kingdom.
Top Retail Stocks To Own Right Now: Calavo Growers Inc (CVGW)
Calavo Growers, Inc. (Calavo), incorporated on January 5, 2001, is a provider of value-added fresh food. The Company is engaged in the marketing and distributing avocados, prepared avocados, and other perishable foods allows them to deliver a wide array of fresh and prepared food products to food distributors, produce wholesalers, supermarkets, convenience stores, and restaurants on a worldwide basis. The Company procures avocados principally from California, Mexico, and Chile. Through its various operating facilities, it sort, pack, and/or ripen avocados, tomatoes and/or Hawaiian grown papayas. Additionally, it also produces salsa and prepares ready-to-eat produce and deli products. It distributes its products both domestically and internationally and reports its operations in three different business segments: Fresh products, Calavo Foods and Renaissance Food Group, LLC (RFG).
Fresh products
The Company�� Fresh products business grades, sizes, packs, cools, and ripens (if desired) avocados for delivery to its customers. It operates two packinghouses and three operating and distributing facilities that handle avocados across the United States.Calavo markets California avocados. In California, the growing area stretches from San Diego County to Monterey County, with the majority of the growing areas located approximately 100 miles north and south of Los Angeles County. The storage life of fresh avocados is limited. It generally ranges from one to four weeks, depending upon the maturity of the fruit, the growing methods used, and the handling conditions in the distribution chain. The Company sells avocados to a diverse group of supermarket chains, wholesalers, food service and other distributors, under the Calavo family of brand labels, as well as private labels. From time to time, some of its larger customers seek short-term sales contracts that formalize their pricing and volume requirements. California avocados delivered to the Company�� packinghouses are graded, size! d, packed, cooled and, frequently, ripened for delivery to customers. The Company imports avocados from Mexico, Chile, Peru, New Zealand and the Dominican Republic. It�� diversified avocado sources provide a level of supply stability that may, over time, help solidify the demand for avocados among consumers in all markets it distribute to.
The Company also handles avocados from Chile, Peru and New Zealand, most of which are on a consignment basis with its growers. Pursuant to its joint venture agreement with M5, Calavo de Chile is the primary contact with its Chilean avocado sources. It has invested in the Aweta AFS (acoustic firmness sensor) technology and equipment. It has three Aweta systems in use in the United States, which, it believe, can effectively meet its customers��demand for conditioned fruit. It has developed various display techniques and packages that appeal to consumers and, in particular, impulse buyers. Some of its techniques include the bagging of avocados and the strategic display of the bags within the produce section of retail stores. The majority of its sales are generated from tomatoes and papayas. Tomatoes are primarily handled on a consigned basis, while papayas are handled on a pooling basis, similar to the California avocado pool previously described.
Calavo Foods
The Company�� Calavo Foods business procures avocados, processes avocados into a wide variety of guacamole products, and distributes the processed product to its customers. All of its prepared avocado products shipped to North America are cold pasteurized and include both frozen and fresh guacamole. The Calavo Foods segment was originally conceived as a mechanism to stabilize the price of California avocados by reducing the volume of avocados available to the marketplace.The Company utilizes ultra high pressure machines which are designed to cold pasteurize its guacamole products. Using high pressure only, this procedure substantially destroys the cells of any b! acteria t! hat could lead to spoilage, food safety, or oxidation issues. Once the procedure is complete, its packaged guacamole is cased and shipped to various retail and food service customers throughout the markets its service. Its IQF line provides food service and retail customers with peeled avocado halves that are ripe and suitable for immediate consumption. These halves were frozen, packaged and shipped out of Mexicali to warehouses located in the United States., and, ultimately, to its customers. The Company�� line of salsa will further diversify its product offerings and will be a natural complement to its ultra-high-pressure guacamole, as well as its Calavo tortilla chips.
RFG
The Company�� RFG business produces markets and distributes nationally a portfolio of healthy, lifestyle products for consumers via the retail channel. RFG is a fresh-food company that produces, markets, and distributes nationally a portfolio of healthy, products for consumers via the retail channel.RFG products range from fresh-cut fruit, ready-to-eat vegetables, recipe-ready vegetables and deli meat products. RFG sells under the labels of Garden Highway Fresh Cut, Garden Highway, and Garden Highway Chef Essentials to a wide range of customers. RFG products range from fresh-cut fruit, ready-to-eat vegetables, recipe-ready vegetables and deli meat products. RFG sells under the labels of Garden Highway Fresh Cut, Garden Highway, and Garden Highway Chef Essentials to a range of customers.
Advisors' Opinion:- [By John Udovich]
Just when you think the global warming (excuse me, climate change)�warnings could not get anymore hysterical or�goofier (Niagara Falls and the Great Lakes have frozen over after all), Chipotle Mexican Grill, Inc (NYSE: CMG) is sounding the alarm (which may rally all of the Sofritas vegan tofu eaters of America)�over�its potential�threat�to�guacamole, but small cap avocado stock Calavo Growers, Inc (NASDAQ: CVGW) continues to grow investor returns no matter what the weather is doing and has outperformed PowerShares DB Agriculture Fund (NYSEARCA: DBA).�First and as noted by ThinkProgress.org, Chipotle Mexican Grill�� latest Annual Form 8-K reported:
- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Sonic Corp (NASDAQ: SONC), Calavo Growers, Inc. (NASDAQ: CVGW), Zep Inc. (NYSE: ZEP) Economic Releases Expected: �Spanish services PMI, Italian services PMI, French services PMI, German services PMI, eurozone services PMI, British services PMI, eurozone investor confidence, German CPI, Australian trade balanceTuesday
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Calavo Growers (Nasdaq: CVGW ) , whose recent revenue and earnings are plotted below.
Top 10 Supermarket Stocks To Own For 2014: Gol Linhas Aereas Inteligentes SA (GOL)
Gol Linhas Aereas Inteligentes S.A. (GoL) is a low-cost, low-fare airline in the world providing service on routes connecting all of Brazil�� cities and from Brazil to cities in South America and select touristic destinations in the Caribbean. As of March 31, 2010, GoL offered approximately 800 daily flights per day to 61 destinations connecting cities in Brazil, as well as destinations in Argentina, Bolivia, Curacao, Aruba, Chile, Colombia, Paraguay, Uruguay and Venezuela. GoL is a holding company, which owns directly or indirectly shares of five subsidiaries: VRG Linhas Aereas S.A. (VRG) and four offshore finance subsidiaries, Gol Finance Cayman and GAC Inc., which owns Sky Finance and Sky Finance II. VRG is the Company�� operating subsidiary, under which it conducts its business. Gol Finance, GAC Inc., Sky Finance and Sky Finance II are off-shore companies established for the purpose of facilitating cross-border general and aircraft financing transactions.
GoL�� passenger transportation services include ticketless travel; online sales, check-in, seat assignment and flight change and cancellation services; online flight status service; Web-enabled cell phone ticket sales and check-in; self check-in at kiosks at designated airports; designated female lavatories; friendly and efficient in-flight service; modern aircraft interiors; quick turnaround times at airport gates; free or discounted shuttle services between airports and drop-off zones on certain routes; buy on board services on certain flights; mobile check-in and boarding pass (100% paperless boarding), and iPhone application for check-in, electronic boarding pass and Smiles account management. On December 31, 2009, the Company had an operational fleet of 108 operational aircraft and a total fleet of 127. As of March 31, 2010, one of its Boeing 767 aircrafts was subleased to a charter company in the United States, one is under final formalization process for a wet lease to a Brazilian company for flights connecting Brazil to! Angola and three are under final stages of negotiation to be chartered to operate intercontinental flights. At December 31, 2009, GoL had a total of 127 aircraft, 94 of which were under operating leases and 33 were under finance leases.
The Company competes with TAM Linhas Aereas S.A.
Advisors' Opinion:- [By Roberto Pedone]
One airline player that's starting to trend within range of triggering a near-term breakout trade is Gol Linhas Aereas Inteligentes (GOL), through its subsidiaries, engages in the air transportation of passengers, cargo, and mailbags in Latin America. This stock has been hammered by the bears so far in 2013, with shares off by 42%.
If you look at the chart for Gol Linhas Aereas Inteligentes, you'll notice that this stock has been uptrending strong for the last two months, with shares moving higher from its low of $2.74 to its recent high of $3.83 a share. During that uptrend, shares of GOL have been mostly making higher lows and higher highs, which is bullish technical price action. Shares of GOL just recently formed a double bottom above its 50-day moving average at $3.57 to $3.55 a share. Shares of GOL are now starting to spike higher above those support levels and move within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in GOL if it manages to break out above some near-term overhead resistance levels at $3.83 to $4.14 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2.19 million shares. If that breakout triggers soon, then GOL will set up to re-test or possibly take out its next major overhead resistance level at its 200-day moving average of $5.30 a share to $6 a share.
Traders can look to buy GOL off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $3.46 a share. One can also buy GOL off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Jake L'Ecuyer]
Gol Linhas Aereas Inteligentes (NYSE: GOL) was down, falling 6.31 percent to $4.0850 after the company posted a loss in the third quarter.
Commodities
In commodity news, oil traded up 1.33 percent to $94.28, while gold traded up 0.28 percent to $1,274.70. - [By Jim Jubak]
One place to look for it this week has been in the ADRs, the New York traded ADRs, American Depository Receipts of GOL. One of the two big Brazilian airlines is the only one that is not owned by somebody else. The symbol is (GOL). It went up like 9.5% on October 21; it went up about 4.5% on October 22, pulled back a tiny little bit on October 23, but still a major, major move. This is basically on the effect of a weaker dollar versus the Brazilian real, since GOL is basically a domestic airline and almost all their revenue is denominated in real, which means that when the real gets cheap against the dollar, it hurts their revenue, especially because most of their costs, a lot of their costs, probably about 80% of their costs are denominated in dollars. A strong dollar means what they pay for oil, kerosene, jet fuel, what they pay for debt service, what they pay on airplane leases, all denominated in dollars, goes up, so GOL has been getting hammered on this. The reversal of this is a big deal for the stock.
- [By Jon C. Ogg]
Gol Linhas A茅reas Inteligentes S.A. (NYSE: GOL) is a Brazilian airline carrier, as well as a mail and cargo carrier. At $4.65, the 52-week trading range is $2.74 to $7.67.
Top 10 Supermarket Stocks To Own For 2014: MicroFinancial Incorporated(MFI)
Microfinancial Incorporated, through its subsidiaries, operates as a specialized commercial finance company that provides microticket equipment leasing and rental, and other financing services in the United States. The company provides financing alternatives, and leases and rents commercial equipment to start-up and established businesses for use in their daily operations. It leases water filtration systems, food service equipment, security equipment, point-of-sale cash registers, salon equipment, health care and fitness equipment, and automotive equipment. The company primarily sources its originations through a network of independent equipment vendors, sales organizations, and other dealer-based origination networks. Microfinancial Incorporated was founded in 1987 and is headquartered in Woburn, Massachusetts.
Advisors' Opinion:- [By Gerrit De Vynck]
Maple Leaf Foods Inc. (MFI), the Canadian producer of foods from hamburgers to frozen pasta, has drawn bids for its bread unit from Grupo Bimbo SAB, Flowers Foods Inc. (FLO) and several private-equity firms, three people with knowledge of the matter said.
- [By Eric Lam]
Alacer Gold Corp. and Iamgold Corp. rallied at least 5.9 percent as the metal traded at its highest in 11 weeks. Maple Leaf Foods Inc. (MFI) jumped 7.8 percent as it agreed to sell a unit for C$645 million ($614 million). Penn West Petroleum (PWT) Ltd. added 1.7 percent after cutting 25 percent of its workforce to reduce costs.
- [By Magic Diligence]
One stock that has been in the official Magic Formula (MFI) screen for the past month or so has piqued my interest: Kraft (KRFT).
The MFI screens, particularly the $50 million screen, are usually reserved for deep value stocks. Usually you find stocks in here suffering serious adverse business developments (LQDT, NSR, etc.), operate in out-of-favor industries (APOL, STRA, etc.), have volatile and difficult-to-predict future prospects (PDLI comes to mind), or are just simply cheap quantitatively (CSCO, COH, et.al.).
Top 10 Supermarket Stocks To Own For 2014: FutureFuel Corp. (FF)
FutureFuel Corp., through its subsidiary, FutureFuel Chemical Company, engages in the manufacture and sale of specialty chemicals and bio-based products primarily in the United States. The company operates in two segments, Chemicals and Biofuels. The Chemicals segment provides custom chemical manufacturing services for specific customers, such as bleach activators for detergent and consumer products manufacturers; proprietary herbicide and intermediates for life sciences companies; agrochemicals; and industrial and consumer products, such as cosmetics and personal care products, ink colorants, adhesion promoters, polymer additives, polymer and specialty dyes, specialty polymers, photographic and imaging chemicals, and food additives. This segment also manufactures and sells a range of performance chemicals, including a family of polymer (nylon) modifiers and small-volume specialty chemicals for various applications; a family of acetal-based solvents, consisting of diethoxy methane, dimethoxymethane, dibutoxymethane, and glycerol formal; and phenol sulfonic acid that build on sulfonations technology. Its chemical products are used in various markets and end uses, including detergents, agrochemicals, automotive, photographic imaging, coatings, nutrition, and polymer additives. The Biofuels segment produces and sells biodiesel, as well as petrodiesel in blends with or without biodiesel. This segment also operates a granary in central Arkansas that involves in the purchase and sale of agricultural commodities, primarily soybeans, rice, and corn. This segment markets its biodiesel products by truck and rail directly to customers. FutureFuel Corp. was formerly known as Viceroy Acquisition Corporation and changed its name to FutureFuel Corp. in 2006. FutureFuel Corp. was incorporated in 2005 and is based in St. Louis, Missouri.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of chemical and biofuels manufacturer FutureFuel (NYSE: FF ) soared 20% on Tuesday after its quarterly results impressed Wall Street.
- [By Maxx Chatsko]
3. Focus on efficiency
A combination of factors plays a role in efficiently producing biodiesel. FutureFuel (NYSE: FF ) , which owns an annual capacity of 59 million gallons to complement its niche chemical business, relies heavily on location. The company's two biorefineries don't have a nationwide infrastructure to aid in getting product to the market and are dependent on rail and barge access. Despite the FutureFuel's amazing progress is improving its process -- annual capacity jumped from just 35 million gallons in 2011 to 59 million gallons today -- the company admits that its relatively small operations may cease to exist given changes in feedstock prices, government mandates, and tax credits. � - [By Monica Gerson]
FutureFuel (NYSE: FF) surged 21.01% to $21.25 in the pre-market session after the company reported a rise in its fourth-quarter earnings. FutureFuel posted its quarterly profit of $0.61 per share, versus a year-ago profit of $0.15 per share.
Top 10 Supermarket Stocks To Own For 2014: Forest Laboratories Inc (FRX)
Forest Laboratories, Inc. (Forest), incorporated on April 11, 1956, develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company�� principal products include Lexapro, its selective serotonin reuptake inhibitor (SSRI) for the treatment of major depressive disorder (MDD) in adults and adolescents and generalized anxiety disorder (GAD) in adults; Namenda, its N-methyl-D-Aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; Savella, its selective serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia and its newest marketed product Teflaro, a broad-spectrum hospital-based injectable cephalosporin antibiotic for the treatment of adults with community-acquired bacterial pneumonia. On April 13, 2011, the Company acquired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.
Aclidinium
In June 2011, the Company ahs submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for aclidinium (aclidinium bromide), a long-acting antimuscarinic agent developed as an inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD). When given by inhalation, aclidinium leads to bronchodilation by inhibiting airway smooth muscle contraction. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Aclidinium is administered to patients using a multi-dose dry powder inhaler (MDPI). This inhaler was designed with a feedback system which, through a ��olored control window��and an a! udible click, helps confirm that the patient has inhaled correctly. It contains multiple doses of aclidinium, includes a visible dose-level indicator, and also incorporates features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.
Linaclotide
Linaclotide is being investigated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC). Linaclotide is an agonist of the guanylate cyclase type-C receptor found in the intestine and acts by a mechanism. Linaclotide increases fluid secretions leading to increased bowel movement frequency and reduces abdominal pain. Linaclotide is administered orally but acts locally in the intestine with no measurable systemic exposure at therapeutic doses and is intended for once-daily administration.
Viibryd
As a result of its acquisition of Clinical Data, Inc. (Clinical Data) completed in April 2011, the Company obtained worldwide rights to develop and market Viibryd (vilazodone HCl) a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist developed by Clinical Data for the treatment of adults with major depressive disorder (MDD). Viibryd became available to patients during the June 2011 quarter and was formally launched in the U.S. in late August 2011.
Daliresp
In February 2011, the Company received approval from the United States Food and Drug Administration (FDA) for the marketing of Daliresp (roflumilast). Daliresp is once-daily, orally administered, selective phosphodiesterase 4 (PDE4) enzyme inhibitor, developed by its partner, Nycomed GmbH (Nycomed), as a treatment to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.
Namenda
Namenda (memantine HCl) is an N-methyl-D-Aspartate (NMDA) receptor agonist for the treatmen! t of mode! rate and severe Alzheimer�� disease. In June 2010, Namenda XR was approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer�� type. Namenda XR is a 28 milligrams once-daily extended-release formulation of Namenda. The Company has obtained the exclusive rights to develop and market memantine in the United States by license agreement with Merz Pharma GmbH & Co. KgaA (Merz) of Germany, the originator of the product.
Bystolic
Bystolic is a beta-1 selective beta-blocker with vasodilating properties. Bystolic decreases heart rate and myocardial contractility and suppresses rennin activity. The Company licensed exclusive United States and Canadian rights to Bystolic from Mylan Inc. (Mylan).
Savella
Savella (milnacipran HCl) is the Company�� selective serotonin and norepinephrine inhibitor (SNRI) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function. The Company licensed the United States and Canadian rights to develop and commercialize Savella from Cypress Bioscience, Inc. (Cypress). Its license agreement includes two patents covering the use of Savella for the management of fibromyalgia.
Teflaro
In October 2010, the Company received marketing approval from the FDA for Teflaro (ceftaroline) for the treatment of adults with community-acquired bacterial pneumonia, including cases caused by Streptococcus pneumoniae bacteremia and with acute bacterial skin and skin structure infections, including cases caused by methicillin-resistant Staphylococcus aureus. Teflaro is a spectrum, hospital-based injectable cephalosporin antibiotic with activity against Gram-positive bacteria and common Gram-negative bacteria. Teflaro is a member of the cephalosporin class of antibiotics. The worldwide rights (excluding Japan) to Teflaro are in-licensed on an exclusive basis from Takeda Pharmaceutical Company (Takeda). Teflaro is als! o covered! by two United States patents that relate to the ceftaroline formulation that expire in 2021 and that may provide additional exclusivity.
Avibactam
Avibactam is designed to be co-administered with select antibiotics to enhance their spectrum of activity. The Company received the exclusive rights to administer avibactam with ceftaroline as a combination product in North America. Avibactam is a beta-lactamase inhibitor designed to be co-administered with select antibiotics to enhance their spectrum of activity by overcoming beta-lactamase-related antibacterial resistance.
Lexapro
Lexapro�� is a SSRI for the treatment of MDD in adults and adolescents and GAD in adults. Lexapro�� (escitalopram oxalate) single isomer version of citalopram HBr, for the treatment of MDD in adults and adolescents and GAD in adults.
Cariprazine
Cariprazine is an oral D2/D3 partial agonist. Cariprazine is also undergoing Phase III trials for schizophrenia and acute mania associated with bipolar depression, bipolar depression and as an adjunct treatment for MDD.
Levomilnacipran
Levomilnacipran is a once-daily, selective norepinephrine and serotonin reuptake inhibitor, two neurotransmitters known to play an essential role in regulating mood, and is being developed for the treatment of MDD.
GRT 6005
In December 2010, the Company entered into a license agreement with Grunenthal GmbH for the co-development and commercialization of GRT 6005 and its follow-on compound GRT 6006, small molecule analgesic compounds being developed by Grunenthal for the treatment of moderate to severe chronic pain. GRT 6005 and GRT 6006 are compounds with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005 has completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III s! tudies.
TTP399
In June 2010, the Company entered into a license agreement with TransTech Pharma, Inc. (TransTech) for the development and commercialization of TTP399, a functionally liver selective glucokinase activator (GKA) discovered and developed by TransTech for the treatment of Type II diabetes. Early Phase I testing suggests that pharmacological enhancement of glucokinase activity may lower blood glucose in diabetic patients.
Azimilide
In April 2011, the Company entered into an agreement with Blue Ash Therapeutics, LLC (Blue Ash) pursuant to which it acquired the worldwide rights to azimilide, a class III antiarrhythmic agent developed by Proctor & Gamble Pharmaceuticals. Based on its mechanism of action and results of clinical trials, azimilide was determined to be suited for use in patients with a history of life-threatening ventricular arrhythmias and who have an implantable cardioverter defibrillator. In 2010, the FDA agreed to one additional Phase III study to support a regulatory submission for azimilide in the U.S.
RGH-618
RGH-618 involves a series of compounds that target metabotropic glutamate receptors and are agonists, which represent potential agents for the treatment of anxiety, depression and other central nervous system (CNS) conditions. In March 2012, the Company initiated a Phase I study in healthy volunteers of RGH-618.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Shares of Forest Laboratories (NYSE: FRX) got a boost, shooting up 15.55 percent to $67.90 after the company announced its plans to acquire Aptalis for $2.9 billion. - [By Anora Mahmudova]
Forest Laboratories Inc. (FRX) �gained 2.6% after the pharmaceuticals firm reported that it swung to a profit in the third-quarter and upgraded its outlook for the current quarter.
- [By Jake L'Ecuyer]
Top Headline
Forest Laboratories (NYSE: FRX) announced its plans to buy Furiex Pharmaceuticals (NASDAQ: FURX) for up to $1.46 billion. Forest will pay around $95 per share, or around $1.1 billion in cash. Forest Labs will also pay up to $30 per share, or around $360 million in a contingent value right. The deal is projected to close in the second or third quarter of 2014. - [By CNNMoney Staff]
Actavis (ACT, Fortune 500) shares were up after it said earnings doubled in the fourth quarter. The company announced plans earlier this week to buy Forest Laboratories (FRX) for $25 billion. Forest shares were also higher.
Top 10 Supermarket Stocks To Own For 2014: C.R. Bard Inc. (BCR)
C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company?s vascular products include percutaneous transluminal angioplasty catheters, chronic total occlusions catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology laboratory systems and diagnostic, therapeutic, and temporary pacing electrode catheters; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachyt herapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; and catheter stabilization devices. The company?s oncology products consist of specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.
Advisors' Opinion:- [By Ben Levisohn]
Intuitive Surgical has gained 4.3% to $397.20 today, easily trumping the gains in other healthcare-equipment companies. �Covidien�(COV) has ticked down 0.3% to $60.08, Medtronic�(MDT) has gained 0.5% to $52.97, Abbott Laboratories�(ABT) has fallen 0.8% to $33.24, and C.R. Bard (BCR) is little changed at $114.52.
Top 10 Supermarket Stocks To Own For 2014: Newcrest Mining Ltd (NCM)
Newcrest Mining Limited (Newcrest) is a gold, copper and silver producer that has operations and exploration projects in Australia, the Pacific region, Asia and West Africa. The Company�� segments include Cadia Valley, Telfer, Gosowong, Lihir, Hidden Valley JV, West Africa (includes Bonikro operations and exploration and evaluation activities in Cote d��voire) and Exploration and Other. Exploration and Other mainly consists of projects in the exploration, evaluation and feasibility phase and includes Namosi in Fiji, Wafi Golpu in Papua New Guinea (PNG), and Marsden and O��allaghans in Australia. Cadia Valley Operations (CVO) is a gold mining operation and is 100% owned by Newcrest. It is located approximately 25 kilometers from the city of Orange in central west New South Wales and is 250 kilometers west of Sydney. Advisors' Opinion:- [By Toshiro Hasegawa]
Honda Motor Co. (7267), which gets 83 percent of sales from overseas, increased 1.9 percent, pacing gains among Japanese exporters. Sony Financial Holdings Inc., the financial services unit of electronics maker Sony Corp., jumped 2.8 percent in Tokyo after proposing a higher dividend. Newcrest (NCM) Mining Ltd. slipped 2.3 percent as brokers cut ratings on shares of Australia�� biggest gold producer.
- [By Jasmine Ng]
Newcrest Mining Ltd. (NCM), Australia�� biggest gold producer, sank 6.7 percent as bullion traded near a five-month low. Hyundai Motor Co., South Korea�� top carmaker, lost 4.2 percent as November sales fell. Sekisui Chemical Co. surged 7.5 percent in Tokyo on a report it developed a material that triples the capacity of electric-vehicle batteries.
No comments:
Post a Comment